CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an <i>ESMO Open-Cancer Horizons</i> pro and con discussion.
Auteurs : Awada A, Gligorov J, Jerusalem G, Preusser M, Singer C, Zielinski C
Jaar : 2019
Journal : ESMO Open
Volume : 4
Pagina's : e000565